Finally, IGFBP1 is negatively associated with impaired glucose tolerance [54] and obesity [55] and serves as a marker of HIS [56], while IGFBP3 correlates directly with hepatic insulin resistance and diabetes incidence [57, 58]. Here, IGFBP1 is linked to obesity due to melanocortin 4 receptor deficiency.